For 34 years, we have been collaborating with global pharma and biotech partners to bring innovative therapies to patients in Central and Eastern Europe. Despite the region's challenging healthcare systems and complex yet promising markets, our team of 400 employees harnesses its expertise to ensure health equity in these underserved markets.

Medis is a member of the World Orphan Drug Alliance (WODA) – a global alliance of full-service regional distributors for orphan and debilitating disease products. WODA covers 152 countries in the following regions: Central and Eastern Europe, Greater China, Israel, Greece, Malta, Cyprus, Latin America, the Middle East, North Africa & Turkey, Switzerland, Australia, New Zealand and South East Asia. 

Out-licensing:
Become our commercialization partner and benefit from advanced, ready-to-launch consumer health products, which are already marketed in 20 countries and are further expanding. 
More information: www.medis.com/en/international-business/ 

Our business areas:
•	Therapeutics 
•	Hospital Care 
•	Consumer Health 
•	Aesthetics 

Our value to partners:
•	Direct local presence in 18 CEE countries 
•	Full commercialization 
•	Single point of contact and delivery 
•	Strategic and localized market access approach 
•	Highest compliance standards 
•	Financial and credit excellence 

Major Partners:
• Therapeutics: Bial – Biogen – Besins – HRA Pharma – Mundipharma – Pierre Fabre – Santen – UCB 
• Hospital Care: Abbott – Aesculap – Asahi Medical – Biotest – B. Braun – Cytosorbents – Paion 
• Consumer Health: Pleuran – Ricerpharma – Karo Healthcare – Merz – Pohl Boskamp – UP – URGO 
• Aesthetics: Merz Aesthetics – Crown Aesthetics 

• Out-licensing partners: Ferrer – Pharmalink – Sarantis – Stada

Pharmaceutical

Therapeutics

Medis

Maja Strnad Cestar

Cvetka Hočevar

Martina Perharič

Tina Vojnovic

Kristina Jeric

Alja Plevnik Kapun

Maja Rojsek

Slavko Pušavec

Erna Slana

Brigita Starešinič

Maja Frelih Pharmd

The Leadership Team at Medis, composed of the CEO, Managing Director Consumer Health Care, Global Chief Financial Officer, and Chief Compliance Officer, is responsible for setting and executing the strategic vision of the company. They lead efforts in expanding international partnerships, ensuring regulatory compliance, maintaining financial stability, and driving commercialization strategies across the therapeutic, hospital care, consumer health, and aesthetics business areas. Their oversight ensures Medis continues to deliver innovative therapies to underserved markets while upholding the highest standards of operational excellence.

Leadership Team

Sales and Account Management

Marketing and Project Management

International Business and Market Access

Leadership Team

About

Team members

Other teams at Medis

Sales and Account Management

Marketing and Project Management

International Business and Market Access